Solid Biosciences Inc.SLDBNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+9.9%
5Y CAGR+12.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+9.9%/yr
vs +13.1%/yr prior
5Y CAGR
+12.2%/yr
Consistent
Acceleration
-3.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$38.41M+15.4%
2024$33.30M+20.0%
2023$27.75M-4.1%
2022$28.95M+6.7%
2021$27.14M+25.7%
2020$21.58M-12.2%
2019$24.58M+38.7%
2018$17.72M+18.5%
2017$14.95M+173.8%
2016$5.46M-